Tom Tu is a Venture Partner at Vensana Capital, where he also serves as CEO of Vensana Innovation, the firm’s innovation engine focused on the creation and building of category-defining medical technology companies. Prior to Vensana, Tom was Chief Medical Officer of Inari Medical, where he helped to develop the company’s core technology platform, execute numerous clinical studies intended to position peripheral thrombectomy as standard of care, and establish Inari as the global leader in the treatment of venous thromboembolism. Prior to his career as a medtech executive, Tom was a practicing interventional cardiologist for nearly two decades, including as the cath lab director and leader of the pulmonary embolism, complex PCI, and TAVR programs at Baptist Health Louisville. Tom graduated with a BA from the University of Virginia and earned an MD from Harvard Medical School. He completed his medical and cardiology training at Massachusetts General Hospital and Beth Israel Deaconess Medical Center and is board certified in interventional cardiology and fellowship trained in peripheral vascular intervention.